HAE241220P60000
- 0.91
- 0.000.00%
Haemonetics Newsroom
Here's Why You Should Add OMCL Stock to Your Portfolio Now
Needham Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $112
Strategic Investment and Growth Potential Drive Buy Rating for Haemonetics
Haemonetics Management to Meet Virtually With BTIG
Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
Raymond James Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $120
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $108 to $125
Haemonetics Second Quarter 2025 Earnings: EPS Misses Expectations
Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript Summary
Haemonetics Corporation (HAE) Q2 2025 Earnings Call Transcript
Haemonetics Is Maintained at Outperform by Barrington Research
Analysts' Opinions Are Mixed on These Healthcare Stocks: AMN Healthcare Services (AMN), DENTSPLY SIRONA (XRAY) and Haemonetics (HAE)
Express News | Haemonetics Corp : Raymond James Raises to Strong Buy From Outperform
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $112 to $125
Haemonetics Analyst Ratings
Haemonetics Earns Buy Rating for Strong Q2 Performance and Margin Improvements
Express News | Haemonetics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
Haemonetics: Fiscal Q2 Earnings Snapshot